Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Costs and expenses:
Research and development	$ 22,009	$ 45,349	$ 45,855	$ 72,119
Selling, general and administrative	10,345	13,808	21,468	26,072
Total costs and expenses	32,354	59,157	67,323	98,191
Loss from operations	(32,354)	(59,157)	(67,323)	(98,191)
Interest expense	(15)	(9,215)	(3,669)	(17,446)
Interest and other income	1,241	3,247	2,363	6,662
Loss on early extinguishment of 2026 convertible senior notes	(2,968)	0	(2,968)	0
Gain on change in fair value of financial instruments	8,207	0	8,142	0
Net loss from continuing operations	(25,889)	(65,125)	(63,455)	(108,975)
Net income from discontinued operations, net of tax			4,571	15,750
Net loss	$ (25,424)	$ (56,041)	$ (58,884)	$ (93,225)
Basic net income (loss) per share:
Net loss from continuing operations (in dollars per share)	$ (0.44)	$ (1.12)	$ (1.09)	$ (1.87)
Net loss from continuing operations (in dollars per share)	(0.44)	(1.12)	(1.09)	(1.87)
Net income from discontinued operations (in dollars per share)	0.01	0.15	0.08	0.27
Net income from discontinued operations (in dollars per share)	0.01	0.15	0.08	0.27
Net loss (in dollars per share)	(0.43)	(0.97)	(1.01)	(1.6)
Net loss (in dollars per share)	$ (0.43)	$ (0.97)	$ (1.01)	$ (1.6)
Weighted-average shares used to compute basic and diluted net income (loss) per share (in shares)	58,585,083	57,944,016	58,323,586	58,374,716